A Critical Analysis of the Specific Pharmacist Interventions and Risk Assessments During the 12-Month TRANSAFE Rx Randomized Controlled Trial.
Haley M GonzalesJames N FlemingMulugeta GebregziabherMaria Aurora Posadas SalasJohn W McGillicuddyDavid J TaberPublished in: The Annals of pharmacotherapy (2021)
A pharmacist-led mHealth intervention may enhance opportunities for pharmacological and nonpharmacological interventions and mitigate risk levels in KTX recipients.